ABSTRACT Motivation: An important goal of microarray studies is to discover genes that are associated with clinical outcomes, such as disease status and patient survival. While a typical experiment surveys gene expressions on a global scale, there may be only a small number of genes that have significant influence on a clinical outcome. Moreover, expression data have cluster structures and the genes within a cluster have correlated expressions and coordinated functions, but the effects of individual genes in the same cluster may be different. Accordingly, we seek to build statistical models with the following properties. First, the model is sparse in the sense that only a subset of the parameter vector is non-zero. Second, the cluster structures of gene expressions are properly accounted for. Results: For gene expression data without pathway information, we divide genes into clusters using commonly used methods, such as K-means or hierarchical approaches. The optimal number of clusters is determined using the Gap statistic. We propose a clustering threshold gradient descent regularization (CTGDR) method, for simultaneous cluster selection and within cluster gene selection. We apply this method to binary classification and censored survival analysis. Compared to the standard TGDR and other regularization methods, the CTGDR takes into account the cluster structure and carries out feature selection at both the cluster level and within-cluster gene level. We demonstrate the CTGDR on two studies of cancer classification and two studies correlating survival of lymphoma patients with microarray expressions.
INTRODUCTION
Microarray technology provides a way of monitoring gene expressions on a large scale. Tremendous efforts have been devoted to discovering genes that are associated with variations of clinical outcomes. Understanding of the molecular biology that underlies such variations might provide a more accurate method of diagnosis and suggest new therapeutic approaches (see e.g. Alizadeh et al., 2000 , Garber et al., 2001 Rosenwald et al., 2003) . Two types of clinical outcomes have been of special interest. The first type is categorical outcome, which includes the presence or absence of tumor as in Alon et al. (1999) or different types of tumors as in Alizadeh et al. (2000) . The second type is survival outcome, which corresponds to the occurrence time of certain event, such as cancer. See for example Rosenwald et al. (2003) and Dave et al. (2004) .
Classification and survival analysis using microarray data are challenging because of the large number of genes and relatively small sample size. Various model reduction methods have been proposed, including the singular value decomposition (Golub and Van Loan, 1996) , partial least squares (Nguyen and Rocke, 2002) , principal component analysis (Ma et al., 2006) , LASSO-LARS (Gui and Li, 2005a) and threshold gradient descent regularization (TGDR), (Gui and Li, 2005b; Ma and Huang, 2005) among others. The essence of the aforementioned techniques is to identify a small number of representative features-individual genes or linear combinations of genes, and build predictive models based on those representative features. In the feature selection, all genes are treated in an equal manner and the intrinsic gene correlation structures are usually ignored.
Statistically speaking, there exist genes whose expressions are highly correlated and should be put into clusters (Tamayo et al., 1999) . Biologically speaking, there exist gene pathways composed of co-regulated genes with coordinated functions (Eisen et al., 1998) . See for example the Gene Ontology (Harris et al., 2004) . Although clusters defined based on statistical correlation and biological functions do not match perfectly, they tend to have certain correspondence (Clare and King, 2002; Tavazoie et al., 1999; Yeung et al., 2001) .
Cluster analysis methods have been employed in microarray studies as a dimension reduction tool (Alizadeh et al., 2000; Dave et al., 2004) . With this approach, a small number of gene clusters are first constructed, using methods such as K-means or hierarchical (Johnson and Wichern, 2002) . The mean expressions of genes within the same clusters are then computed and used as covariates for downstream model building. A limitation of this approach is that feature selection is carried out only at the cluster level. Once a cluster is used in the final model, all genes within that cluster are included. Although genes within the same cluster may have correlated expressions, it is not necessarily true that they will all be associated with a specific clinical outcome. Including noisy genes may lead to ill-behaved models. Gene selection within clusters is still needed to yield more reliable models. Wei and Li (2006) propose a nonparametric pathwaybased regression approach that explicitly makes use of available pathway information. They used the gradient-based boosting algorithm (GDB) (Friedman, 2001) for model fitting and the importance score (Breiman et al., 1984; Friedman, 2001) for ranking pathways and genes. However, they did not explicitly consider variable selection at either the cluster or individual gene levels.
Regularization methods, such as the LASSO and TGDR are effective methods for variable selection. Although capable of selecting a small number of important genes, these methods do not incorporate cluster structure. On the other hand, standard approaches using cluster analysis results as input explicitly take into account cluster structure, but cannot carry out individual gene selection.
To combine strength of the aforementioned approaches, we propose a clustering TGDR (CTGDR) method that incorporates cluster structure into TGDR-based variable selection. The proposed CTGDR carries out feature selection at two levels: at the cluster level and the individual gene level within each cluster. Thus it takes advantages of both the cluster-based and regularized variable selection methods.
In Section 2, we present the data and models that we consider. We use logistic regression for binary classification and Cox model for right censored survival analysis as examples. We select the optimal number of clusters using the Gap statistic. The CTGDR algorithm is described in Section 3. Tuning parameter selection and evaluation are also discussed. We present two classification examples in Section 4 and two survival analysis examples in Section 5. The article ends with discussions in Section 6.
DATA AND MODEL SETTINGS
Let Z be a length d vector of gene expressions, and let Y be the clinical outcome of interest. We assume that Y is associated with Z through model Y $ f(b 0 Z) with a regression function f and unknown regression coefficient b. In addition, we assume there exists a smooth objective function and a proper estimate of b can be obtained by maximizing that function. We are particularly interested in the classification and survival analysis problems using microarray gene expression data due to their extensive applications in biomedical studies.
Binary classification
For the classification problems, Y is a categorical variable indicating the disease status. For simplicity, we focus on binary classification only. Suppose that Y ¼ 1 denotes the presence and Y ¼ 0 indicates the absence of disease. We assume the commonly used logistic regression model, where the logit of the conditional probability
Here b is the length d vector of unknown regression coefficient and a is the unknown intercept. Based on a random sample of n observations
. . , n, the maximum likelihood estimator is defined as ðâ a‚b bÞ ¼ argmax a‚ b R n ða‚ bÞ, where
For simplicity, we denote R n (a,b) as R n (b).
Cox survival analysis
. Here U and V denote the event time of interest and censoring time, respectively. The most widely used model for censored survival data are the Cox model (Cox, 1972) , which assumes that the conditional hazard function l(u j Z) ¼ l 0 (u)exp(b 0 Z). l 0 is the unknown baseline function and b is the regression coefficient. Based on a random sample of n observations
. . , n, the partial likelihood estimator is defined as the valueb b that maximizes
where r i ¼ {j : T j ! T i } is the risk set at time T i .
Cluster structure
The proposed CTGDR approach assumes the cluster structure has been well-defined. Some gene expression data have well defined biological gene pathways. Such cluster structure can be obtained from web databases, such as the GO (http://www.geneontology.org) See for e.g. Wei and Li, (2006) . However it is also well known that the pathway information may be only partially or even not available for a large number of genes. In this case, we propose defining cluster structure based on statistical measurements (Tamayo et al., 1999) . Commonly used clustering methods include the hierarchical, K-means, tree-truncated vector quantization and self-organizing map methods, among many others. For a general reference, see Gordon (1999) . In general there does not exist optimal clustering method. In this article, we consider the two most popular unsupervised approaches: hierarchical and K-means methods.
We use the Gap statistic (http://www-stat.stanford.edu/~tibs/ftp/ jcgs.ps) (Tibshirani et al., 1999) to select the optimal number of clusters. For a chosen clustering approach, we first choose L max -the largest number of clusters. Then for
(1) Generate L clusters using the selected approach. Denote rss L as the total within block sum of squares.
(2) Create a new dataset by separately permuting each gene expression measurements. Apply the clustering method to the permuted expression data. Letr ss rss L denote the resulting within cluster sum of squares. Repeat this for a number of times and compute the average aveðr ss rss L Þ.
Choose the value L that maximizes gap(L). We refer to Tibshirani et al. (1999) and McLachlan et al. (2004) for detailed discussions of the Gap statistic. We assume gene j ¼ 1, . . . , d belongs to one of the clusters C( j) 2 {1, . . . , L}.
CLUSTERING TGDR
The CTGDR can be consider a generalization of the TGDR, which is introduced by Friedman and Popescu (2004) (http://www-stat. stanford.edu/~jhf/PathSeeker.html) in the context of linear regression analysis and has been employed in microarray studies by Gui and Li (2005b) and Ma and Huang (2005) . For completeness, we first briefly describe the TGDR algorithm.
TGDR algorithm
Denote Dn as the small positive increment as in ordinary gradient descent methods (Friedman and Popescu, 2004) . In the implementation of this algorithm, we choose Dn ¼ 1 · 10
as the index for the point along the parameter path after k steps. Let b(n k ) denote the parameter estimate corresponding to n k . For any fixed threshold 0 t 1, the TGDR algorithm consists of the following steps:
(1) Initialize b(0) ¼ 0 and n 0 ¼ 0.
(2) With current estimate b, compute the negative gradient
(3) Compute the threshold vector f(n) of length d, where the j-th component of f(n):
and update n by n + Dn, where the product of f and g is component-wise.
(5) Steps 2-4 are repeated k times. The number of iterations k is determined by cross validation.
The tuning parameters t and k jointly determine the property of b. When t % 0, b is dense even for small values of k. When t % 1, b is sparse for small k and remains so for a relatively large number of iterations, but will become dense eventually. At the extreme when t ¼ 1, the TGDR usually increases in the direction of a single covariate in each iteration. When t is in the middle range, the characteristics of b are between those for t ¼ 0 and t ¼ 1. For t 6 ¼ 0, variable selection can be achieved with cross validated, finite k, by having certain components of b exactly zero. We refer to Friedman and Popescu (2004) for more detailed discussions. The TGDR described here is capable of individual gene selection but does not account for the cluster structure.
Naive CTGDR
Naive CTGDR Algorithm I. This algorithm modifies step 3 of the TGDR as follows: where 0 t 1 1 is the threshold tuning parameter. The other steps in the TGDR are kept unchanged. Compared to the original TGDR, algorithm I uses cluster gradients to replace individual gradients. The combined effects of genes in the same clusters are considered and compared with the combined effects of other clusters. This algorithm is similar to the traditional clustering approaches in the sense that gene selection is achieved on a cluster basis, and if the combined effect of genes in a cluster is important, then all the genes within this cluster will be included in the final model. The key difference is that the naive CTGDR I estimated coefficients of genes in the same clusters may be different. So genes within the same clusters may still have different contributions in the final model, whereas in traditional cluster based methods, all genes within the same clusters have the same coefficient and hence equal contributions to the outcome.
Algorithm I does feature selection at the cluster level. If a cluster is selected, then all the genes in this cluster are selected. Thus the total number of genes in the final model can be large. Consider for an example a hypothetical study with 2000 genes and five clusters of equal sizes are constructed. Then using algorithm I, it is possible three or four clusters are selected. The total number of genes in the final model will be >1000. Although the prediction performance may still be satisfactory, this makes the final estimation results hard to interpret from a gene discovery point of view. Since it is often the case that only a subset of genes within each cluster have important impact on the outcome of interest, gene selection within cluster is still needed.
Naive CTGDR Algorithm II. This algorithm partly solves the drawbacks of algorithm I. Denote t 2 2 [0,1] as the threshold tuning parameter. We replace f in step 3 of the TGDR with
so that each gene is only compared with other genes within the same cluster and only important genes from each cluster are selected. The rationale is that genes from different clusters may not be directly comparable. So a fair comparison should be for genes within the same clusters.Within each cluster, we use the TGDR to identify important genes.
We have employed algorithm II in the examples in Sections 4 and 5. We are able to identify a smaller number of genes ($200, much fewer than that from naive algorithm I) with satisfactory prediction performance. However, algorithm II has its own drawbacks. It is roughly equivalent to carrying out the TGDR in each cluster separately and the final model includes genes selected from all clusters. The underlying assumption is that all clusters are associated with the outcome of interest. Previous cluster based methods as in Dave et al. (2004) and Alizadeh et al. (2000) show that this is not necessarily true. Cluster selection is still needed.
CTGDR algorithm
The naive CTGDR algorithm I carries out cluster selection, but does not select important genes within each cluster. On the other hand, the naive CTGDR algorithm II does gene selection in each cluster separately, but does not select clusters. The advantages and drawbacks of the naive CTGDR algorithms motivate the following CTGDR algorithm.
Let t 1 ,t 2 2 [0,1] be two threshold parameters. In step 3 of the TGDR algorithm, define
where f 1 (n) is defined in Equation (2) with threshold value t 1 and f 2 (n) is defined in Equation (3) with threshold value t 2 , respectively. In Equation (4), the term f 1 (n) carries out cluster selection, while f 2 (n) carries out within-cluster gene selection. So the combined f can carry out feature selection at both the cluster level and within cluster level. Further flexibility is introduced by allowing two possibly different threshold values. In this algorithm, if a gene or a cluster is known to be associated with the clinical outcome a priori, then it can be excluded from the thresholding step.
The three tuning parameters k, t 1 and t 2 jointly determine the properties of the CTGDR estimates. The t 1 and t 2 have similar effects as the tuning parameter t for the standard TGDR in Section 3.1. If t 1 and t 2 are both close to 1, then the estimate remains sparse for a relatively large k, but will become dense eventually. If t 1 and t 2 are both close to 0, the estimate is dense for even a very small k. t 1 and t 2 determine the degree of sparsity on cluster level and within cluster level, respectively, with larger thresholding values leading to more parsimonious models with fixed k. With nonzero t 1 and t 2 , the model with small to moderate k usually has a small number of clusters and a small number of genes within each selected cluster. 
Possible extensions
where w j is the positive weight measuring the relative importance of cluster j. A simple choice of w j is the inverse of cluster size, so that the relative importance of clusters is not affected by cluster size. If external knowledge about the relative importance of genes within the same cluster is present, then the cluster gradient can be defined as the weighted sum of individual gradients, with more stable and more important genes having larger weights. Further flexibility can be introduced by considering weighted gradients.
Tuning parameter selection
We select the tuning parameters k and (t 1 ,t 2 ), which jointly determine the characteristics of the estimator, using the following two-step approach. First we choose the tuning parameter k for any fixed (t 1 ,t 2 ) using V-fold cross validation (Wahba, 1990) as follows. Partition the data randomly into V non-overlapping subsets of equal sizes. Choose k to maximize the cross-validated objective function
where b (Àv) is the CTGDR estimate of b based on the data without the v-th subset for a fixed k and R ðÀvÞ n is the objective function R n evaluated without the v-th subset. In our study, we set V ¼ 5.
After cross validation over k, model features for different t 1 and t 2 can be obtained. We choose parsimonious models with relatively large CV score. An AIC type score as in Huang et al. (2006) can be used as model selection criterion. Cross validation over t 1 and t 2 can also be considered, i.e. we can select the model with the largest CV score over all possible k. t 1 and t 2 . However, this approach may lead to models with slightly larger CV scores, but a lot more genes, which may be less stable models.
Evaluation
Unlike in standard classification or survival analysis where the association between clinical outcome and covariates is of primary interest, studies given in Sections 4 and 5 put more emphasis on selection of important genes and prediction. So we consider the following cross validation based approach for evaluating prediction performance, as suggested in Ma and Huang (2005) .
(1) We first partition the data randomly into a training set of size n 1 and a testing set of size n 2 with n 1 + n 2 ¼ n. In this article, we set n 1 $ 2/3n.
(2) Compute the CTGDR estimate based on the training set only. Using this training set estimate, we compute a prediction index for the testing set.
(3) To take into account the possibility of an extreme prediction performance due to a rare partition, we repeat this process B (e.g. 200) times. Each time a new partition is made and the prediction index is computed.
For classification studies, the prediction index can be the prediction error. For censored survival studies, we first create two risk groups based on dichotomizing the estimated linear risk scoresb b 0 Z i at the median risk score for the testing set. We then use the Logrank statistic to assess whether the survival curves of different risk groups are different. A large value of the Logrank statistic indicates that the high-and low-risk groups are well separated, and suggests satisfactory prediction performance of the CTGDR estimate.
BINARY CLASSIFICATION

Colon data
In this dataset, expression levels of 40 tumor and 22 normal colon tissues for 6500 human genes are measured using the Affymetrix gene chips. A selection of 2000 genes with the highest minimal intensity across the samples has been made by Alon et al. (1999) , and these data are publicly available at http://microarray.princeton. edu/oncology/. The colon data have been analyzed in several previous studies using other statistical approaches, (see for e.g. Dettling and Buhlmann, 2003; Pochet et al., 2004; Nguyen and Rocke, 2002 and Huang, 2005) .
Nodal data
This dataset was first presented by West et al. . We threshold the raw data with a floor of 100 and a ceiling of 16 000. Genes with max(expression)/ min(expression) <10 and/or max(expression) À min(expression) <1000 are also excluded (Dudoit et al., 2002) . A total of 3332 (46.7%) genes pass the first step screening. A base 2 logarithmic transformation is then applied. This data have also been studied by Dettling and Buhlmann (2003) . We first identify 500 genes for each dataset based on marginal significance to gain further stability as in Ma and Huang (2005) . Compute the sample standard errors of the d genes se (1) , . . . , se (d) and denote their median as med.se. Compute the adjusted standard errors as 0.5(se (1) + med.se), . . . , 0.5(se (d) + med.se). Then the genes are ranked based on the t-statistics computed with the adjusted standard errors. A total of 500 genes with the largest absolute values of the adjusted t-statistics are used for classification.
For the Colon and Nodal data, we construct the clusters using the K-means and hierarchical methods. The number of clusters is chosen using the Gap statistic. For the Colon data, we show in Figure 1 the Gap statistic as a function of L. Since it has been suggested that the clusters should not be too small on average (Dave et al. 2004 ), we set L max ¼ 50. For the Colon data, the Gap statistic yields the optimal number of clusters 9 (K-means) and 23 (hierarchical); for the Nodal data, 10 (K-means) and 11 (hierarchical).
We apply the CTGDR to the clustered data obtained above. We consider the tuning parameters t 1 and t 2 taking values in the grid 0, 0.1, . . . , 1.0. Model features selected via cross validation are shown in Table 1 . For the Colon data, 13 (K-means) and 15 (hierarchical) genes are selected in the final models, representing 5 and 3 clusters. For the Nodal data, 33 (K-means) and 18 (hierarchical) genes are selected in the final models, representing 5 and 2 clusters. The estimated coefficients and gene descriptions for the final models are available upon request.
We evaluate the prediction performance of the CTGDR using the approach discussed in Section 3.5. For comparison, we also consider three alternatives: (1) a simple clustering approach, where the clusters are the same as used under the CTGDR. The within cluster median expressions are used as covariates. This mimics the approach in Dave et al. (2004) . We refer to this approach as K-means-simple or Hierarchical-simple, depending on the clustering methods used; (2) Logistic model with TGDR for variable selection and (3) Logistic model with LASSO for variable selection, where the tuning parameter u is the L 1 norm of b. For the TGDR and LASSO, the tuning parameters are also chosen via 5-fold cross validation.
For the Colon data, the CTGDR yields mean prediction errors 0.111 based on 200 random partitions under both the K-means and hierarchical clustering. Simple clustering approaches yield mean prediction errors 0.166 and 0.222; The TGDR approach has mean prediction error 0.149 and the LASSO yields prediction error 0.170. The CTGDR also has better prediction performance than the SMRC in (Ma and Huang, 2005 ) (mean classification error 0.14), the boosting (Dettling and Buhlmann, 2003 For the Nodal data, the mean prediction errors are 0.143 with the CTGDR under both clustering schemes. Simple clustering based approach has less optimal prediction errors 0.228 and 0.177. The TGDR and LASSO mean prediction errors are 0.147 and 0.222, respectively. Applying the SMRC approach as in Ma and Huang (2005) , we get mean prediction error 0.147. The prediction performance of the CTGDR is better than the boosting based approaches (mean classification errors 0.184, 0.265 and 0.224) and 1-nearest neighbor (mean classification error 0.367) and classification tree (mean classification error 0.204). See details in Dettling and Buhlmann (2003) .
SURVIVAL ANALYSIS
Follicular lymphoma data
Follicular lymphoma is the second most common form of nonHodgkin's lymphoma, accounting for about 22% of all cases. A study was conducted to determine whether the survival probability of patients with follicular lymphoma can be predicted by the geneexpression profiles of the tumors at diagnosis (Dave et al., 2004) . Fresh-frozen tumor-biopsy specimens and clinical data from 191 untreated patients who had received a diagnosis of follicular lymphoma between 1974 and 2001 were obtained. The median age at diagnosis was 51 years (range 23-81), and the median follow up time was 6.6 years (range <1.0-28.2). The median follow up time among patients alive at last follow up was 8.1 years. Eight records with missing survival information are excluded from the downstream analysis. Affymetrix U133A and U133B microarray genechips were used to measure gene expression levels from RNA samples. A log2 transformation was applied to the Affymetrix measurements. We first filter the 44 928 gene measurements with the following criteria: (1) the max expression value of each gene across 191 samples must be >9.186 (the median of the maximums of all probes). (2) The max-min should be >3.874 (the median of the max-min of all probes). (3) Compute correlation coefficients of the uncensored survival times with gene expressions. Select the genes whose correlations with survival time are >0.2. There are 729 genes that pass this screening process. We normalize genes across samples to have mean 0 and variance 1. Rosenwald et al. (2003) reported a study using microarray expression analysis in mantle cell lymphoma (MCL). Among 101 untreated patients with no history of previous lymphoma included in this study, 92 were classified as having MCL, based on established morphologic and immunophenotypic criteria. Survival times of 64 patients were available and other 28 patients were censored. The median survival time was 2.8 years (range 0.02-14.05 years). Lymphochip DNA microarrays (Alizadeh et al., 2000) were used to quantify mRNA expression in the lymphoma samples from the 92 patients. The gene expression data that contains expression values of 8810 cDNA elements is available at http://llmpp.nih. gov/MCL. We pre-process the data as follows to exclude noises and gain further stability: (1) Compute the variances of all gene expressions; (2) Compute correlation coefficients of the uncensored survival times with gene expressions and (3) Select the genes with variances larger than the first quartile and with correlation coefficients >0.25. 834 out of 8810 genes pass the above initial screening. We standardize these genes to have zero mean and unit variance. For the Follicular data, the Gap statistic yields optimal number of clusters equal to 34 (K-means) and 24 (hierarchical), respectively. Plot similar to Figure 1 can be generated and is omitted here. We show model features with cross validation selected tuning parameters in Table 2 . Under the hierarchical clustering, the largest cluster has 347 genes and all genes with nonzero coefficients in the CTGDR model come from this cluster. For evaluation, we compute the Logrank test statistics from random partitions. For comparison, we also consider three alternatives: the simple clustering based approach as in classification study, the simple TGDR as described in Section 3.1, and the LASSO approach as in Gui and Li (2005a) . We can see from Table 2 that the CTGDR coupled with K-means or hierarchical clustering have the best prediction performance. The K-means-CTGDR has slightly better prediction than the Hierarchical-CTGDR, but the difference is not dramatic.
Mantel cell lymphoma data
For the MCL data, the optimal number of clusters are 30 and 13 under K-means and hierarchical clustering, respectively. Model features with optimal tuning parameters are also shown in Table 2 . One dominating cluster is also present under the hierarchical method, which leads to all genes identified by CTGDR coming from this cluster. In Figure 2 , we show the kernel-smoothed histograms of the predictive Logrank statistics calculated from random partitions as described in Section 3.5 for different approaches. The K-means-CTGDR method has the best prediction performance in terms of the predictive Logrank statistic. However, the TGDR is slightly better than the hierarchical-CTGDR, but the difference is very small.
DISCUSSIONS
The proposed CTGDR approach can carry out feature selection at the cluster and individual gene levels simultaneously, and directly accounts for cluster structures in microarray gene expression data. This algorithm is quite flexible in that it can use any clustering results, including those based on gene annotation, as input in the analysis. We use logistic regression for classification and Cox model for survival data as examples to illustrate the effectiveness of the CTGDR. However, the CTGDR algorithm does not depend on the actual form of the objective function, as long as it is welldefined and differentiable. So the CTGDR can be used in survival analysis with other models, such as the accelerated failure time and additive hazards models, and classification analysis based other objective functions, such as the SVM hinge loss and the ROC objective function.
We have demonstrated the proposed approach on four publicly available datasets. In these examples, there do not exist well-defined biological clusters. So we constructed the clusters using two popular approaches: the K-means (a top-down approach) and the hierarchical (bottom-up) methods. We used the Gap statistic to determine the optimal number of clusters. For the four datasets we considered, Clustering TSGDR comparing to several existing methods, the CTGDR has better prediction performance by simultaneously accounting for the cluster structure and carrying out two-level feature selection. We note that there exist quite a few alternative clustering approaches, for example the self-organizing map. However there exists no optimal clustering method. We only demonstrate the two popular ones in this study. It is possible that other clustering approaches or other ways of determining optimal number of clusters can also lead to models with satisfactory prediction. Comparison of different clustering schemes is beyond the scope of this paper. When there exist well-defined biological clusters (e.g. biological pathways), the proposed CTGDR can utilize that information.
The essential idea of the CTGDR is to carry out feature selection simultaneously at two levels. Specifically, CTGDR is a combination of TGDR at the cluster level and TGDR at the gene level within cluster. With the same spirit, combinations of different regularization approaches can in fact be considered. For example, we can use TGDR for within cluster selection and LASSO for cluster selection. Considering that there are many variable selection methods, the combinations will have a very long list and it is beyond the scope of the current manuscript to conduct a thorough investigation.
We have only considered classification and survival models in which the outcome variable depends on a simple linear combination of the gene expression data. The CTGDR is applicable to more complicated models, which may include nonparametric and nonlinear components. It is also applicable to models with interactions at both the cluster and individual gene levels. Such models would probably be more realistic from a biological standpoint. We plan to consider such issues in future studies.
